Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19

This article aims to summarize the evidence on the use of RAS inhibitors in CVD patients with COVID-19, focusing on safety issues of the RAS inhibitors and their relationship with COVID-19.
Source: American Journal of Cardiovascular Drugs - Category: Cardiology Source Type: research